Verastem, Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Verastem, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2021-09-30 was $28.00M.
- Verastem, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2020-03-31 was $57.41M.
- Verastem, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2024 was $21.16M.
- Verastem, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2021 was $28.00M, a 51.23% decline from fiscal 2020.
- Verastem, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2020 was $57.41M, a 503.28% increase from fiscal 2019.
- Verastem, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2019 was $9.52M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2024-12-31 | $21.16M 10-K · filed 2026-03-04 | |
| 2021-12-31 | $28.00M 10-K · filed 2024-03-14 | |
| 2021-09-30 | $28.00M 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $57.41M 10-K · filed 2023-03-14 | |
| 2020-03-31 | $57.41M 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $9.52M 10-K · filed 2022-03-28 | |
| 2012-12-31 | $68.15M 10-K · filed 2015-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |